Notice of Annual General Meeting

AI SummaryClose X

Solvonis Therapeutics plc has announced the notice of its 2026 Annual General Meeting, which will be held on June 19, 2026, at 9:00 am at its registered office. The company, which develops small-molecule therapeutics for central nervous system disorders, has posted the notice and proxy form to shareholders and submitted them to the National Storage Mechanism. This announcement is procedural and does not contain new financial performance data or strategic updates that would directly impact the stock share price.

Disclaimer*

UK 100

Latest directors dealings